ZARMONY

Serial Number 77698941
606

Registration Progress

Application Filed
Mar 25, 2009
Under Examination
Mar 9, 2010
Approved for Publication
Nov 25, 2009
Published for Opposition
Dec 15, 2009
Registered

Trademark Image

ZARMONY

Basic Information

Serial Number
77698941
Filing Date
March 25, 2009
Published for Opposition
December 15, 2009
Abandonment Date
October 11, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 11, 2010
Classes
005

Rights Holder

Bristol-Myers Squibb Company

03
Address
345 Park Avenue
New York, NY 10154

Ownership History

Bristol-Myers Squibb Company

Original Applicant
03
New York, NY

Bristol-Myers Squibb Company

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Nadine P. Flynn

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Oct 12, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Oct 11, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 9, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 15, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 25, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Nov 12, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 5, 2009 ALIE A ASSIGNED TO LIE Loading...
Nov 5, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 5, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 5, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 28, 2009 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 10, 2009 CNRT F NON-FINAL ACTION MAILED Loading...
Jun 9, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 30, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 28, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "ZARMONY" has no meaning in a foreign language.

Classification

International Classes
005